These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

857 related articles for article (PubMed ID: 33261212)

  • 1. The Development of Maillard Reaction, and Advanced Glycation End Product (AGE)-Receptor for AGE (RAGE) Signaling Inhibitors as Novel Therapeutic Strategies for Patients with AGE-Related Diseases.
    Shen CY; Lu CH; Wu CH; Li KJ; Kuo YM; Hsieh SC; Yu CL
    Molecules; 2020 Nov; 25(23):. PubMed ID: 33261212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phytochemicals as Potential Inhibitors of Advanced Glycation End Products: Health Aspects and Patent Survey.
    Fernandes ACF; Melo JB; Genova VM; Santana ÁL; Macedo G
    Recent Adv Food Nutr Agric; 2022 Nov; 13(1):3-16. PubMed ID: 34053432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phytochemicals Against Advanced Glycation End Products (AGEs) and the Receptor System.
    Yamagishi SI; Matsui T; Ishibashi Y; Isami F; Abe Y; Sakaguchi T; Higashimoto Y
    Curr Pharm Des; 2017; 23(8):1135-1141. PubMed ID: 27774900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Glyoxalase in Glycation and Carbonyl Stress Induced Metabolic Disorders.
    Saeed M; Kausar MA; Singh R; Siddiqui AJ; Akhter A
    Curr Protein Pept Sci; 2020; 21(9):846-859. PubMed ID: 32368974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phytochemicals against anti-diabetic complications: targeting the advanced glycation end product signaling pathway.
    Parveen A; Sultana R; Lee SM; Kim TH; Kim SY
    Arch Pharm Res; 2021 Apr; 44(4):378-401. PubMed ID: 33837513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of advanced glycation end products in cellular signaling.
    Ott C; Jacobs K; Haucke E; Navarrete Santos A; Grune T; Simm A
    Redox Biol; 2014; 2():411-29. PubMed ID: 24624331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fructose causes endothelial cell damage via activation of advanced glycation end products-receptor system.
    Sotokawauchi A; Matsui T; Higashimoto Y; Yamagishi SI
    Diab Vasc Dis Res; 2019 Nov; 16(6):556-561. PubMed ID: 31375034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of Advanced Glycation End Product (AGE) Formation and Accumulation.
    Sourris KC; Watson A; Jandeleit-Dahm K
    Handb Exp Pharmacol; 2021; 264():395-423. PubMed ID: 32809100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of advanced glycation endproduct formation by foodstuffs.
    Wu CH; Huang SM; Lin JA; Yen GC
    Food Funct; 2011 May; 2(5):224-34. PubMed ID: 21779560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gliclazide alters macrophages polarization state in diabetic atherosclerosis in vitro via blocking AGE-RAGE/TLR4-reactive oxygen species-activated NF-kβ nexus.
    Jahan H; Choudhary MI
    Eur J Pharmacol; 2021 Mar; 894():173874. PubMed ID: 33460615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Food-derived advanced glycation end products (AGEs): a novel therapeutic target for various disorders.
    Yamagishi S; Ueda S; Okuda S
    Curr Pharm Des; 2007; 13(27):2832-6. PubMed ID: 17897026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Advanced Glycation Endproduct (AGE)-Receptor for Advanced Glycation Endproduct (RAGE) Axis in Cardiovascular Disease and Its Therapeutic Intervention.
    Yamagishi SI
    Circ J; 2019 Aug; 83(9):1822-1828. PubMed ID: 31366777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting advanced glycation with pharmaceutical agents: where are we now?
    Borg DJ; Forbes JM
    Glycoconj J; 2016 Aug; 33(4):653-70. PubMed ID: 27392438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the Receptor for Advanced Glycation Endproducts (RAGE): A Medicinal Chemistry Perspective.
    Bongarzone S; Savickas V; Luzi F; Gee AD
    J Med Chem; 2017 Sep; 60(17):7213-7232. PubMed ID: 28482155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of Advanced Glycation End Products With Cardiovascular Disease in Menopausal Women.
    Pertynska-Marczewska M; Merhi Z
    Reprod Sci; 2015 Jul; 22(7):774-82. PubMed ID: 25228634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses.
    Basta G; Lazzerini G; Massaro M; Simoncini T; Tanganelli P; Fu C; Kislinger T; Stern DM; Schmidt AM; De Caterina R
    Circulation; 2002 Feb; 105(7):816-22. PubMed ID: 11854121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulation by Processed Animal Feed: The Role of Maillard Reaction Products and Advanced Glycation End-Products (AGEs).
    Teodorowicz M; Hendriks WH; Wichers HJ; Savelkoul HFJ
    Front Immunol; 2018; 9():2088. PubMed ID: 30271411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of pheophorbide a as an inhibitor of receptor for advanced glycation end products in Mallotus japonicus.
    Matsumoto T; Matsuno M; Ikui N; Mizushina Y; Omiya Y; Ishibashi R; Ueda T; Mizukami H
    J Nat Med; 2021 Jun; 75(3):675-681. PubMed ID: 33625682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced glycation end product ligands for the receptor for advanced glycation end products: biochemical characterization and formation kinetics.
    Valencia JV; Weldon SC; Quinn D; Kiers GH; DeGroot J; TeKoppele JM; Hughes TE
    Anal Biochem; 2004 Jan; 324(1):68-78. PubMed ID: 14654047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced glycation end products and insulin resistance.
    Unoki H; Yamagishi S
    Curr Pharm Des; 2008; 14(10):987-9. PubMed ID: 18473850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.